Isolated renal tuberculosis following intravesical Bacillus Calmette-Guérin therapy for bladder cancer. 2004

Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
Department of Urology, Kumamoto University School of Medicine, Kumamoto, Japan. yoshiwada@kaiju.medic.kumamoto-u.ac.jp

We present a case of isolated renal tuberculosis following bacillus Calmette-Guérin (BCG) therapy for bladder cancer. In the presurgical radiographic examination, we suspected an atypical renal cell carcinoma. According to the diagnosis of renal cell carcinoma, we performed a radical nephrectomy. The histological findings were tuberculosis-specific inflammatory changes and the patient received an antituberculous multiple drug therapy for a year. It is concluded that we should pay attention to the possibility of a renal tuberculosis granuloma in any patient who presented with subacute formed renal masses following BCG treatment before deciding on the strategy of the treatment of the renal masses, especially in patients who had received such a treatment which induced an immunocompromised state.

UI MeSH Term Description Entries
D008297 Male Males
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000283 Administration, Intravesical The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms. Bladder Drug Administration,Drug Administration, Bladder,Instillation, Bladder,Intravesical Drug Administration,Administration, Intravesical Drug,Injections, Intravesical,Intravesical Administration,Intravesical Injection,Intravesical Instillation,Administration, Bladder Drug,Administrations, Bladder Drug,Administrations, Intravesical,Administrations, Intravesical Drug,Bladder Drug Administrations,Bladder Instillation,Bladder Instillations,Drug Administration, Intravesical,Drug Administrations, Bladder,Drug Administrations, Intravesical,Injection, Intravesical,Instillation, Intravesical,Instillations, Bladder,Instillations, Intravesical,Intravesical Administrations,Intravesical Drug Administrations,Intravesical Injections,Intravesical Instillations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D014398 Tuberculosis, Renal Infection of the KIDNEY with species of MYCOBACTERIUM. Renal Tuberculoses,Renal Tuberculosis,Tuberculoses, Renal

Related Publications

Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
April 2020, Medical archives (Sarajevo, Bosnia and Herzegovina),
Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
September 2017, Urology,
Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
November 1988, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
January 2008, Urologia internationalis,
Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
July 2023, International cancer conference journal,
Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
March 2000, The Israel Medical Association journal : IMAJ,
Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
October 1987, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
December 1987, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
January 1989, European urology,
Yoshihiro Wada, and Yutaka Sugiyama, and Hiroaki Kikukawa, and Tomohiro Kuwahara, and Wataru Takahashi, and Tomi Takamiya, and Shoichi Ueda
March 2017, The Cochrane database of systematic reviews,
Copied contents to your clipboard!